EP2404901
1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.12.2008EP published:
20.11.2013EP application number:
11184000.5
EPO information:
European Patent Register
Max expiry date:
30.11.2028
Title:
1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
Timeline
Today
1.12.2008EP application
20.11.2013EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Mogi, MunetoAddress:
Waltham, MA Massachusetts, US
Name:
Kawanami, ToshioAddress:
Boston, MA Massachusetts, US
Name:
Yamada, KenAddress:
Boston, MA Massachusetts, US
Name:
Yasoshima, KayoAddress:
Cambridge, MA Massachusetts, US
Name:
Imase, HidetomoAddress:
Cambridge, MA Massachusetts, US
Name:
Miyake, TakahiroAddress:
Kobe-shi, Hyogo, JP
Name:
Ohmori, OsamuAddress:
Izunokuni-shi, Shizuoka, JP
Priority
Number:
991891 PDate:
3.12.2007Country:
US
Classification
Categories:
C07D 207/14, C07D 403/12, C07D 403/14, C07D 401/14, C07D 405/14, C07D 413/14, A61K 31/40, A61P 3/06